#
#
#
#
##
##
##
|||||||
|---|---|---|---|---|---|
|ils|||||~Pa e No|
|Foreword .||||||
|Statement ofTrustee Responsibilities||.||||
|Trustee Report .||||||
|Trustee Report Appendices|||||15|
|Appendix
A - Schedule of|Charitable||Funds|||
|Appendix B - Donated Income Policy||||||
|Appendix
C - Investment|Guidelines|||||
|Appendix
D - Invested Pool Guidelines||||for Restricted Funds||
|Appendix E - Reserves policy||||||
|Appendix F - General Purpose Guidelines||||||
|Financial Statements
2020/21|||||25|
|Statement ofFinancial Activities .|||||26|
|Balance Sheet .|||||27|
|Cash flow Report .|||||28|
|Notes to the Accounts|||||29|
|Auditor's
Opinion .|||||43|
#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
#
#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
#
#
##
|||2020-21|2020-21|2020-21|2020-21|2019-20|2019-20|2019-20|2019-20|
|---|---|---|---|---|---|---|---|---|---|
||Note|Unrestricted
Funds|Restricted
Funds|Endowment
Funds|Total Funds|Unrestricted
Funds|Restricted
Funds|Endowment
Funds|Total Funds|
|||f000|8000|1000|fooo|f000|5000|4000|f000|
|Income snd||||||||||
|Endowments
from:||||||||||
|Donations
dt Legacies|2.1|0|1,446|0|1,446|0|2,440|0|2,440|
|Other Trading activities|2.2|0|0|0|0|0|4|0|4|
|Investments|23|0|247|0|247|0|290|0|290|
|Total Income dr Endowments||0|1,693|0|1,693|0|2,734|0|2,734|
|Expenditure
on:||||||||||
|Raising funds|3|0|357|0|357|0|403|0|403|
|Charitable
activities|4|0|1,134|0|1,134|0|3,187|0|3,187|
|Governance|5|0|52|0|52|0|46|0|46|
|Total Expenditure||0|1,543|0|1,543|0|3,636|0|3,636|
|Net Gains / (Losses) on
Investments|8|0|1,714|(I)|1,713|0|(1,150)|(I)|(1,151)|
|Net Income
/ (Expenditure)|||1,864|(I)|1,863|0|(2,052)|(I)|(2,053)|
|Transfers between
funds|||0|0|0|0|0|0|0|
|Net movement
in funds|6|0|1,864|(I)|1,863|0|(2,052)|(I)|(2,053)|
|Reconciliation
offunds:||||||||||
|Fund balances carried forward at
MARCH 2020|31||6,385|80|6,465|0|8,437|81|8,518|
|Fund balances carried forward
MARCH 2021|at 31||8,249|79|8328|0|6885|80|6,465|
|The notes at pages 29 to 42 form|part ofthese financial|statements.||||||||
##
|||||||Unrestricted|Restricted|Endowment|Total at|Urlrcstrlcted|Restncted|Endowment|Total at|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||Notes|Funds|Funds|Funds|31March|Funds|Funds|Funds|31March|
|||||||31.03.21|31.03.21|31.03.21|2021|31.0320|31.03.20|310320|2020|
|||||||fOOD|f000|f000|f000|fsss|8000|8000|foas|
|Fixed assets:||||||||||||||
|Investments|||||8|0|8,911|79|8,990|0|7,705|80|7,785|
|Total Fixed Assets||||||0|8,911|79|8,990|0|7,705|80|7,785|
|Current assets:||||||||||||||
|Stocks||||||||||||0|6|
|Debtors|||||10||153||153||178|0|178|
|Cash at bank|||and in hand||||1,396||1,396||1,539|0|1,539|
|Total Current Assets||||||0|1,554|0|1,554|0|1,723|0|1,723|
|Creditors: Amounts
falling due
within one year|||||11.1|0|1,335|0|I/35|0|2,237|0|2,237|
|Net Current Assets||/|(Liabilities)|||0|219|0|219|0|(514)|0|(514)|
|Total Assets less Current||||Liabilities||0|9,130|79|9,209|0|7,191|80|7,271|
|Creditors: Amounts
than one year||falling||due after more|I1.2|0|881|0|881|0|806|0|806|
|Total Net Assets||||||0|8,249|79|8,328|0|6,385|80|6,465|
|Funds ofthe Charity||||||||||||||
|Capital Funds:||||||||||||||
|Endowment||funds|||121|0||79|79|0|0|80|80|
|Income Funds;||||||||||||||
|Restncted|income|||funds|125|0|8,249|0|8,249|0|6,385|0|6,385|
|Unrestricted|||funds|||||||0|0|0||
|Total charity funds||||||0|8,249|79|8,328|0|6,385|80|6,465|
##
||||||Total|Total|
|---|---|---|---|---|---|---|
||||||2020/21|2019/20|
||||||5000|OOOO|
|Cash flows from Operating
Activities:|||||||
|Net Cash|provided
by (used in) operating|activities|||~898|~238|
|Cash flows from investing
activities:|||||||
|Returns
on Investments|||||247|290|
|Proceeds|from sale ofinvestments||||3,737|4,568|
|Purchase|ofInvestments||||(3,229)|(4,317)|
|Net cash|provided
by (used in) investing|activities|||755|541|
|Change in cash and cash equivalents|||||(143)|303|
|Cash and|Cash equivalents
at the start of||the year||1,539|1,236|
|Cash and|Cash equivalents
at the end ofthe year||||1,396|1,539|
|ReconciTiation ofnet income
/ (expenditure)||||to net cash flow from Operating|activities||
|Net income
/ (expenditure)
as per the SOFA|||||1,863|(2,053)|
|Dividends|and Interest from Investments||||(247)|(290)|
|(Increase)|/ decrease in Stocks||||||
|(Increase)|/ decrease in Debtors||||25|(51)|
|Increase/|(decrease) in Creditors||||(827)|1,005|
|(Increase)|/ decrease in Investment
Gains / Losses||||(1,713)|1,151|
|Net cash|(outflow)
/ inflow from operating||activities||(898)|(238)|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|S Musson|Chair|
|---|---|
|M Eastwood|Non Executive Director|
|D Fillingham|Non Executive Director (to 30th July 2020)|
|I Ismail|Non Executive Director (from 1st September 2021)|
|TJohnston|Non Executive Director|
|Prof L Kenny|Non Executive Director (to 30th June 2021)|
|A Phillips|Non Executive Director (to 30th September 2020)|
|S Samuels|Non Executive Director (from 1st September 2020)|
|Ede Souse|Non Executive Director (from 1st September 2020)|
|ProfTWalley|Non Executive Director (froml st July 2021)|
|M Weame|Non Executive Director (to 31st August 2021)|
|N Willcox|Non Executive Director|
|S Warbuton|Chief Executive Ofticer (to 5th September 2021)|
|D Dalton|Interim Chief Executive Officer (from 6th September 2021)|
|D Brown|Chief Nurse (to 3rd October 2021)|
|E Ingtesby-Burke|Interim Chief Nurse (from 4th October 2021)|
|TCope|Medical Director (to 17th October 2021)|
|J Brennan|Interim Medical Director (fiom 18th October 2021)|
|R Forster|Deputy Chief Executive Oflicer &Chief Finance Offiver|
|D Herring|Chief People OAicer|
|BWeston|Chief Operating
Officer|
|Donations|dt|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Legacies|||2.1|||||||||||
||||||||||Unrestricted
2020-21
Funds|Restricted
2020-21
Funds|Endowment
2020-21
Funds|Total
2020-21
Funds|Total
2019-20 Funds|
||||||||||f000|f000|f000|f000|fooc|
|||||Donations||||||1,313||1,313|1,897|
|||||Legacies||||||133||133|543|
|||||Total|||||0|1,446|0|1,446|2,440|
|Trading||||||||||||||
|Activities|||2.2|||||||||||
||||||||||Unrestricted
2020-21|Restricted
2020-21|Endowment
2020-21|Total
2020-21|Total
2019-20 Funds|
||||||||||Funds|Funds|Funds|Funds||
||||||||||5000|fsgs|f000|1000|f000|
|||||Fundiaising||||||||||
|||||Total|||||0|0|0|0|4|
|Investment||||||||||||||
|Income|||2.3|||||||||||
||||||||||Unrestricted
2020-21|Restricted
2020-21|Endowment
2020-21|Total
2020-21|Total
2019-20Funds|
||||||||||Funds|Funds|Funds|Funds||
||||||||||f000|8000|8000|8000|8000|
|||||Dividends||and investment||Interest||247||247|281|
|||||Bank Interest||||||||||
|||||Total|||||0|247|0|247|290|
|Expenditure||on||||||||||||
|Raising funds||||||||||||||
||||||||||Unrestricted
2020-21
Funds|Restricted
2020-21
Funds|Endowment
2020-21
Funds|Total
2020-21
Funds|Total
2019-20Funds|
||||||||||f000|5000|fees|f000|f000|
|||||Fundraising||Costs||||305||305|348|
|||||Investment||Management||||52||52|55|
|||||Total|||||0|357|0|357|403|
|Expenditure||on||||||||||||
|Charitable||||||||||||||
|Activities|||4|||||||||||
||||||||||Unrestricted|Restricted|Endowment|Total||
||||||||||2020-21|2020-21|2020-21|2020-21|Total
2019-20 Funds|
||||||||||Funds|Funds|Funds|Funds||
||||||||||f000|f000|5000|8000|f000|
|||||Patients Welfare gi amenities||||||77||77|447|
|||||Staff Welfare|||&amenities|||733||733|390|
|||||Research|di Education|||||249||249|733|
|||||Contrihuiions|||to NHS Capital|||75||75|1,617|
|||||Total|||||0|1,134|0|1,134|3,187|
|Other|||||||||
|---|---|---|---|---|---|---|---|---|
|||||Unrestricted
2020-21
Funds|Restricted
2020-21
Funds|Endowment
2020-21
Funds|Total
2020-21
Funds|Total
2019-20 Funds|
|||||5000|5000|5000|8000|1000|
|||Governance|||52||52|46|
|||Total|||||52||
|Allocation|and||||||||
|Apportion
Governance|to|||Basisof
Allocation|Allocated to
Governance|Residual for
Apportion|Total
2020-21
Funds|Total
2019-20 Funds|
|Costs|||||||||
||||||f000|5000|5000|fOOO|
|||Salanes||Time Spent|28|63|91|99|
|||Establishment|Costs|Governance|||||
|||Audit Fee||Governance||||10|
|||Misceganeous||Governance|12||13||
|||Total|||52|64|116|116|
|Apportion|of||||||Support|Total costs|Total costs|
|---|---|---|---|---|---|---|---|---|---|
|Support Costs||s.l||||5000|Costs
f000|2020-21
5000|2019-20
f000|
||||Expendiuuu
on raising Funds:|||||||
||||Fundraising|||291|14|305|348|
||||Investment
Management|||39|13|52|55|
||||Sub - Total|||330|27|357||
||||Expenditure
on Charitable||Activities:|||||
||||Patients Welfare &||amenities|74||77|447|
||||Staff Welfare|&,amenities||709|24|733|390|
||||Research|||241||249|733|
||||Contnbutions|to NHS Capital||73||75|1,617|
||||Sub - Total|||1,097|37|1,134|3,187|
||||Governance||||52|52|46|
||||Total Expenditure|||1,427|116|1,543|3,636|
|Charity|||||||||||Grants to|Grants to|Support|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Activities|by||||||||||Institutions|individuals|Costs 2020-|Total|Total|
|Type||5.3|||||||||2020-21|2020-21|21|2020-21|2019-20|
||||||||||||f000|f000|8000|8000|f000|
||||Patients Welfare||||k amenities||||74|||77|447|
||||Staff Welfare||k||amenities||||450|259|24|733|390|
||||Research||||||||241|||249|733|
||||Contributions||to||NHS|Capital|||73|||75|1,617|
||||Total||||||||838|259|37|1,134|3,187|
|Grants||||||||||||||||
|awarded|to|||||||||||||Total|Total|
|insitutions||5.4||||||||||||2020-21|2019-20|
|||||||||||||||8000|f000|
||||Liverpool|Univemity||||Hospital||NHS FT/||||||
||||Royal Liverpool||||k Broadgreen|||University||||794|2,941|
||||Hospitals|NHS||Trust||||||||||
||||University|of|Liverpool|||||||||44|185|
|||||||||||||||838|3,126|
|Changes|in|||||||||||||||
|Resources||||||||||||Restricted|Endowment|Total|Total|
|Available|for||||||||||Unrestricted|2020-21|2020-21|2020-21|2019-20|
|Charity|Use|6|||||||||2020-21 Funds|Funds|Funds|Funds|Funds|
||||||||||||8000|8000|8000|f000|f000|
||||Net movement|||in funds for the||||year||1,864||1,863|(2,053)|
||||Net movement|||in tangible|||frxixt assets|||||||
||||Net movement|||in funds available||||||||||
||||||||||||0|1,864|(1)|1,863|(2,053)|
||||||2020-21|2019-20|
|---|---|---|---|---|---|---|
|8.1|Fixed Asset Investments:||||8000|5000|
||Market value at|31 March 2020|||7,785|9,187|
||Less: Disposals|at carrying value|||(3,737)|(4,568)|
||Add: Acquisitions
at cost||||3,Z29|4,317|
||Net gain on revaluation||||1,713|(1,151)|
||Market value at|31 March 2021|||8,990|7,785|
||Historic cost at|31March 2021|||7,898|8,407|
||||Held in|Held outside|2020-21|2019-20|
|8.2|Market value at|31 March:|UK|UK|Total|Total|
||||f.000|f000|8000|5000|
||Investments
listed on the Stock Exchange||8,878||8,878|7,505|
||Cash held as part ofthe investment||112||112|280|
||portfolio||||||
||||8,990||8,990|7,785|
|||||||Total as at|Total as at 31|
|---|---|---|---|---|---|---|---|
|Analysis|of|10||||31 MARCH|MARCH|
|Debtors||||||2021|2020|
|||10.1|Amounts|falling due within one year:||8000|f000|
||||||Prepayments|||
||||||Accrued income|151|178|
||||Total debtors falling due within one year|||153|178|
|||10.2|Amounts|falling due over one year:||||
||||Total debtors falling due after more than one year|||||
||||Total debtors|||153|178|
|||||||Total as at|Total as at 31|
|Analysis|of|||||31MARCH|MARCH|
|Creditors||||||2021|2020|
|||11.1|Amounts|falling due within one year:||8000|f000|
||||||Other creditors|152|302|
||||||Accruals|1,183|1,935|
||||||Deferred income|||
||||Total creditors||falling due within one year|1,335|2,237|
|||11.2|Amounts|falling due atter more than one year:||||
||||||Accruals|881|806|
||||Total creditors||falling after more than one year|881||
||||Total creditors|||2,216|3,043|
|Analysis of|12|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|Funds||||||||||||
||12,1|Endowment|Funds 31.03.21||Balance 31
March 2020|Incoming
Resources|Resources
Expended||Transfers|Gains and
Losses|Balance 31
March 2021|
|||(list|individually)||f000|f000||f000|1000|f000|fggg|
|||A||M A Device|20||||||19|
|||||S IVCooke|16||||||13|
|||||Dr1Bernstein||||||||
|||||Mr N Gibbon|41||||||42|
|||Others||(I)||||||||
|||Total||||0||0|0|(I)|79|
|Details of|IE2|||Name offund|Description of|the nature|and purpose of||each fund|||
|material||A||MA Device|Bed endowment|fund for Patients||Welfare||||
|funds-||||SI V Cooke|Holiday
fund for Nurses|||||||
|Endowment||||Dr J Bernstein|RLUH Convalescence
and recreation
fund|||||||
|Funds 31.03.21||D||Mr N Gibbon|Annual
Urology|Scholatship||||||
||12.3|Endowment|Funds 31.03.20||Balance 31
March 2019|Incoming
Resources|Resources
Expended|||Gains snd
Losses|Balance 31
March 2020|
|||gist|individually)||2000|f000||f000|f000|f000|f000|
|||A||M A Device|20||||||20|
|||B||S IV Cooke|16||||||16|
|||C||DrJBernstein||||||||
|||D||Mr N Gibbon|42||||||41|
|||Others||(I)||||||||
|||Total|||81|0||0|0|(I)|00|
|Details of|12.4|||Name offund|Description of|the nature|and purpose of||each fund|||
|material||||M A Device|Bed endowment|fund for Patients||Welfare||||
|funds-||||S IV Cooke|Holiday
fund for Nurses|||||||
|Endowment||||Dr J Bernstein|RLUH Convalescence
and||recreation
fund|||||
|Funds 31.03.20||D||Mr N Gibbon|Annual
Urology|Scholarship||||||
|Analysis of
Funds|12|cont'd|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||12.5|Restricted|Funds|31.03.21||||Balance 31
March 2020|Incoming
Resources|Resources
Expended||Transfers|||Gains and
Losses||Balance 31
March 2021||
|||||||||6000|5000|5000|||(000||5000|||5000|
|||Maierialfunds|||||||||||||||||
|||(hst mdividuagy)|||||||||||||||||
|||||Endocrinology|Fund|||703|23|(17)||||||156||865|
|||||RLUH General|Purpose|||511|286|(241)||||||252||808|
|||||L'pool Reg Dialysis||Fund||662|24|(102)||||||163||747|
|||||RLBUHT General Purpose||||231|1,020|(723)||||||54||582|
|||||RLUH Patient|Welfare||Fund|399|35|(3)||||||59||490|
|||||Forget Me Not|Fund|||475|24|(124)||||||100||475|
|||G||BGH Haematology||Fund||346|13|(8)||||||76||427|
|||||RLUH Renal Transplant|||Fund|266||(6)||||||59||328|
|||Others(98)||||||2,792|259|(319)||||||795||3,527|
|||Total||||||6,385|1,693|(1,543)||||0|1,714|||8,249|
|Details of|12.6|||Name of fund||||Description ofihe nature and||purpose ofeach|||fund||||||
|material||||Endocrinology|Fund|||Any chantable|purpose
relating|to disease||ofthe gland|||||||
|funds-||||RLUH General|Purpose|||Any charilable|purpose
relating|to Royal Liverpool||||University|Hospital||||
|Restricted||||L'pool Reg Dialysis||Fund||Any chantable|purpose
rais tmg|to Dialysu||services|||||||
|Funds 31.03.21||||RLBUHT General
Purpose||||Any charilable|purpose
relatmg|to Royal Liverpool||||& Broadgreen||University|Hospitals||
|||||RLUH Patients|Welfare||Fund|For the rehef ofRLUH patients||suffering|from sickness and disease or its effects||||||||
|||||Forget Me Not|Fund|||Any charitable|purpose
relating|to cancer||services|||||||
|||||BGH Haematology||Fund||Any charilable|purposes
relating|to Haemalology|||Unit||||||
|||||RLUH Renal Transplant|||Fund|Any chanlable|purpose
relating|to Renal Transplant||||Unit|||||
||12.7|Restricted|Funds|31.03.20||||Balance 31
March 2019|Incoming
Resources|Resources
Expended||Transfers|||Gains and
Losses||Balance 31
March 2020||
|||||||||6000|f000|5000|||f000|||5000||5000|
|||Material||funds|||||||||||||||
|||(list individually)|||||||||||||||||
|||||Endocrinology|Fund|||1,272|35|(20)|||(500)|||(84)||703|
|||||RLUH General|Purpose|||583|466|(848)||||500|(190)|||511|
|||||L*pool Reg Dialysis||Fund||875|30|(121)|||||(122)|||662|
|||||RLBUHT General
Purpose||||19|261|(2)||||||(47)||231|
|||||RLUH Patient|Welfare||Fund|413||(19)||||||||399|
|||||Forget Me Not|Fund|||670|1,386|(1,540)||||||(41)||475|
|||||BGH Haematology||Fund||392|13|P)||||||(52)||346|
|||||RLUH Renal Transplant|||Fund|303||(6)||||||(40)||266|
|||Others (98)||||||3,910|529|(1,073)|||||(574)|||2,792|
|||Total||||||8,437|2,734|(3,636)||||0|(1,150)|||6,385|
|Details of|12.8|||Name offund||||Description ofthe nature and||purpose ofeach|||fund||||||
|material||||Endocrinology|Fund|||Any charitable|purpose
relating|to disease||ofthe gland|||||||
|funds-||||RLUH General|Purpose|||Any charitable|purpose
relating|lo Royal Liverpool||||University|Hospital||||
|Restricted||||L*pool Reg Dialysis||Fund||Any charitable|purpose
relating|lo Dialysis services|||||||||
|Funds 31.03.20||||RLBUHT General Purpose||||Any charitable|purpose
relating|lo Royal Liverpool||||& Broadgreen||University|Hospitals||
|||||RLUH Patients|Welfare||Fund|For the relief of RLUH patients||suffenng||from sickness and disease or its effects|||||||
|||||Forget Me Not|Fund|||Any charitable|purpose
relating|lo cancer||services|||||||
|||||BGH Haematology||Fund||Any charitable|purposes
relaltng|lo Haemalology|||Unit||||||
|||||RLUH Renal Tmnsplant|||Fund|Any charitable|purpose
relating|lo Renal Transplant||||Unit|||||
|Contingencies|13|There were no contingent
assets|or liabilities|or liabilities|for the charity included|for the charity included|for the charity included|in|the accounts:|||
|---|---|---|---|---|---|---|---|---|---|---|---|
|Commitments,|14.1|The Charity has no commitments,||liabilities|or provisions.|||||||
|Liabliities and||||||||||||
|Provisions||||||||||||
||14.2|The Trustee recognise ltabtlities|tn the accounts once they have||||incurred||either a|||
|||legal or constructive
obligation|to|expend funds.||||||||
|Trustee and|15|||||||||||
|Connected||||||||||||
|Persons|15.1|Trustee expenses reimbursed||||||||2020-21|20I9-20|
|Transactions|||||||||||f.|
|||Travel snd subsistence|||||||||0|
|||Entertainment||||||||||
|||Other (please describe)||||||||||
|||Total number of Trust Board Members representing||||the Trustee||||||
||15.2|There was no Trustee remuneration||||||||||
||15.3|There were no transactions
with|a|Trustee or connected persons|||in any|||||
|||personal
capacity||||||||||
||15.4|Trustee Indemnity
Insurance||||||||||
|||Cover provided
under Liverpool|University||Hospitals|NHS Foundation|||Trust's|||
|||Litigation
Authority
Non-clinical||risk scheme.||||||||
##
|Name, nature ofconnection,|Name, nature ofconnection,|||2020-21|2020-21||2019-20|2019-20||
|---|---|---|---|---|---|---|---|---|---|
|description ofactivities undertaken|||Turnover|of|Net Profit/|Turnover|of|Net|Profit/|
|and details ofany qualifications|||Connected||(Loss) for the|Connected||Loss|for the|
|expressed|by their auditors||Organisation||Connected|Organisation||Connected||
||||||Organisation|||Organisation||
||||||f||||f|
|Liverpool|University
Hospitals|NHS FT||||||||
|(formerly|Royal Liverpool R Broadgreen||1,109,384,000||1,410,000|693,482,000||283,159,000||
|University|Hospitals
NHS Trust)|||||||||
##
##
##
##
##
##
##
##
##
##
##